Header Logo

Connection

Alan Go to Percutaneous Coronary Intervention

This is a "connection" page, showing publications Alan Go has written about Percutaneous Coronary Intervention.
Connection Strength

3.301
  1. Coronary artery bypass grafting and percutaneous coronary intervention in patients with end-stage renal disease. Eur J Cardiothorac Surg. 2015 May; 47(5):e193-8.
    View in: PubMed
    Score: 0.513
  2. Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2015 Apr 14; 65(14):1411-20.
    View in: PubMed
    Score: 0.511
  3. Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention. Am Heart J. 2015 Jan; 169(1):149-54.
    View in: PubMed
    Score: 0.495
  4. Temporal trends in mortality after coronary artery revascularization in patients with end-stage renal disease. Perm J. 2014; 18(3):11-6.
    View in: PubMed
    Score: 0.468
  5. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med. 2013 May 21; 158(10):727-34.
    View in: PubMed
    Score: 0.448
  6. Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Am Heart J. 2013 May; 165(5):800-8, 808.e1-2.
    View in: PubMed
    Score: 0.444
  7. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol. 2016 06; 9(6).
    View in: PubMed
    Score: 0.138
  8. Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease. Am J Cardiol. 2016 May 15; 117(10):1596-1603.
    View in: PubMed
    Score: 0.136
  9. Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA. 2013 Jul 10; 310(2):155-62.
    View in: PubMed
    Score: 0.113
  10. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Am J Med. 2016 06; 129(6):592-599.e1.
    View in: PubMed
    Score: 0.034

© 2024 Kaiser Permanente